793695-89-3 Usage
Description
(5-IODO-2-METHOXYPHENYL)METHANAMINE, with the molecular formula C8H10INO, is an organic iodine compound and a derivative of methanamine. It is characterized by its potential for versatile chemical reactions and its applications in the synthesis of pharmaceuticals and agrochemicals. (5-IODO-2-METHOXYPHENYL)METHANAMINE has garnered attention in the field of medicinal chemistry due to its possible biological and pharmacological activities.
Uses
Used in Pharmaceutical Synthesis:
(5-IODO-2-METHOXYPHENYL)METHANAMINE is used as a key intermediate in the synthesis of various pharmaceuticals for [application reason, e.g., treating specific medical conditions or targeting particular biological pathways].
Used in Agrochemical Production:
In the agrochemical industry, (5-IODO-2-METHOXYPHENYL)METHANAMINE is used as a building block for the development of new agrochemicals aimed at [application reason, e.g., enhancing crop protection or improving agricultural productivity].
Used in Organic Synthesis:
As a versatile building block in organic synthesis, (5-IODO-2-METHOXYPHENYL)METHANAMINE is used for [application reason, e.g., creating new compounds with specific properties or functions].
Used in Medicinal Chemistry Research:
In the field of medicinal chemistry, (5-IODO-2-METHOXYPHENYL)METHANAMINE is utilized for [application reason, e.g., investigating its potential biological activities or pharmacological effects].
Check Digit Verification of cas no
The CAS Registry Mumber 793695-89-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,9,3,6,9 and 5 respectively; the second part has 2 digits, 8 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 793695-89:
(8*7)+(7*9)+(6*3)+(5*6)+(4*9)+(3*5)+(2*8)+(1*9)=243
243 % 10 = 3
So 793695-89-3 is a valid CAS Registry Number.
793695-89-3Relevant articles and documents
PURINE DERIVATIVES AS A3 AND A1 ADENOSINE RECEPTOR AGONISTS
-
Page/Page column 28, (2010/10/20)
Disclosed are (N)-methanocarba adenine nucleosides of the formula: [Formula] as highly potent A3 adenosine receptor agonists, pharmaceutical compositions comprising such nucleosides, and a method of use of these nucleosides, wherein R1-R6 are as defined in the specification. These nucleosides are contemplated for use in the treatment a number of diseases, for example, inflammation, cardiac ischemia, stroke, asthma, diabetes, and cardiac arrhythmias. The invention also provides compounds that are agonists of both A1 and A3 adenosine receptors for use in cardioprotection.
